Skip to main content
logo
CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
56.18
-0.20 (-0.35%)
At close: May 29, 2026, 4:00 PM EDT
55.17
-1.01 (-1.80%)
After-hours: May 29, 2026, 7:58 PM EDT

CRISPR Therapeutics AG Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4.13.5137.31371.211.2914.96
Revenue Growth (YoY)
-89.11%-90.59%-89.95%30885.48%-99.87%127154.94%
Gross Profit
4.13.5137.31371.211.2914.96
Selling, General & Admin
71.4373.5472.9876.16102.4699.69
Research & Development
377.15381.06310.24387.33461.65340.57
Other Operating Expenses
201.92213.48120.67130.25110.25101.18
Total Operating Expenses
650.5668.08503.88593.74674.36541.44
Operating Income
-646.4-664.57-466.57-222.54-673.16373.53
Pretax Income
-565.17-577.97-362.67-150.72-650.5379.53
Provision for Income Taxes
3.363.633.592.89-0.331.87
Net Income
-568.53-581.6-366.25-153.61-650.18377.66
Net Income to Common
-568.53-581.6-366.25-153.61-650.18377.66
Shares Outstanding (Basic)
929084797876
Shares Outstanding (Diluted)
929084797880
Shares Change (YoY)
8.24%6.60%6.49%1.90%-3.29%21.90%
EPS (Basic)
-6.22-6.47-4.34-1.94-8.364.97
EPS (Diluted)
-6.22-6.47-4.34-1.94-8.364.70
Shares Outstanding
96.3995.8985.7480.0478.5176.99
Free Cash Flow
-401.18-345.93-144.68-269.85-532.93457.27
Free Cash Flow Per Share
-4.34-3.85-1.71-3.41-6.855.69
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-15754.20%-18933.60%-1250.38%-59.95%-56190.40%40.82%
Profit Margin
-13856.50%-16569.80%-981.54%-41.38%-54271.70%41.28%
FCF Margin
-9777.63%-9855.50%-387.72%-72.69%-44484.90%49.98%
EBITDA
-627.33-645.09-447.31-202.7-648.99391.48
EBITDA Margin
-15289.60%-18378.70%-1198.76%-54.61%-54172.70%42.79%
EBIT
-646.4-664.57-466.57-222.54-673.16373.53
EBIT Margin
-15754.20%-18933.60%-1250.38%-59.95%-56190.40%40.82%
Effective Tax Rate
-0.60%-0.63%-0.99%-1.92%0.05%0.49%
SEC Filings: 10-K · 10-Q